Solaro. Increased contractility and altered Ca 2ϩ transients of mouse heart myocytes conditionally expressing PKC␤. Am J Physiol Cell Physiol 280: C1114-C1120, 2001.-Activation of protein kinase C (PKC) in heart muscle signals hypertrophy and may also directly affect contractile function. We tested this idea using a transgenic (TG) mouse model in which conditionally expressed PKC␤ was turned on at 10 wk of age and remained on for either 6 or 10 mo. Compared with controls, TG cardiac myocytes demonstrated an increase in the peak amplitude of the Ca 2ϩ transient, an increase in the extent and rate of shortening, and an increase in the rate of relengthening at both 6 and 10 mo of age. Phospholamban phosphorylation and Ca 2ϩ -uptake rates of sarcoplasmic reticulum vesicles were the same in TG and control heart preparations. At 10 mo, TG skinned fiber bundles demonstrated the same sensitivity to Ca 2ϩ as controls, but maximum tension was depressed and there was increased myofilament protein phosphorylation. Our results differ from studies in which PKC␤ was constitutively overexpressed in the heart and in studies that reported a depression of myocyte contraction with no change in the Ca 2ϩ transient.
IN EXPERIMENTS PRESENTED HERE, we used a binary transgenic (TG) mouse model in which a constitutively active ␤-isoform of protein kinase C (PKC) was conditionally expressed at a low level in the heart. PKC␤ is normally expressed in fetal heart, declines after birth (20, 21) , and remains low in abundance throughout normal adult life (2) . There are, however, several lines of evidence indicating that the PKC␤ isoform is upregulated during development of cardiac hypertrophy. Hypertrophy induced by pressure overload in rats is associated with an increased level of PKC␤ isoform expression (12) . Moreover, samples of failed human heart demonstrate an increase in PKC␤ expression and an increase in its contribution to total PKC activity (3) .
To test the hypothesis that upregulation is an important element in the hypertrophic pathway, increased levels of the PKC␤ isoform have been induced using TG approaches. Wakasaki et al. (27) reported that cardiacspecific and robust overexpression of the PKC␤ isoform in TG mice induced a cardiomyopathy, which was characterized by left ventricular hypertrophy, myocardial fibrosis, and decreased in vivo left ventricular performance. However, Bowman et al. (4) , who employed conditional and relatively low expression of the PKC␤ transgene in adult mice, reported that modest upregulation caused mild and progressive ventricular hypertrophy without significant pathological changes. Compared with controls, these hearts did, however, exhibit reduced rates of rise and fall of left ventricular pressure in open-chest preparations. In contrast, overexpression of PKC␤ in newborns resulted in sudden death marked by abnormalities in the regulation of intracellular Ca 2ϩ in myocytes. In the case of mouse hearts subjected to high levels of constitutive expression of the PKC␤ isoform, Takeishi et al. (26) reported that myocyte shortening was depressed with no change in the peak amplitude of the Ca 2ϩ transients. Associated with this effect was an increase in troponin I (TnI) phosphorylation. This finding led to the speculation that a reduction in myofilament activation, previously shown to be caused by PKC-dependent phosphorylation of cardiac troponin I (cTnI) (14, 18, 19) , may be a critical mechanism for heart failure. Thus the mechanism by which PKC␤ may be involved in the hypertrophic-failure process appears to depend on the timing of the upregulation of the enzyme as well as on variable effects of upregulation on Ca 2ϩ homeostasis and on myofilament response to Ca 2ϩ . To test this idea, we induced expression of PKC␤ in TG mice at 10 wk of age and studied ventricular preparations at 6 and 10 mo of age. We compared preparations from controls and TG hearts with regard to 1) mechanical function and intracellular Ca 2ϩ transients of ventricular myocytes, 2) protein phosphorylation profiles of cellular proteins, 3) Ca 2ϩ dependence of tension in skinned fiber bundles, and 4) Ca 2ϩ transport rate of sarcoplasmic reticulum (SR) vesicles. Our results indicate that low-level expression of PKC␤, which may mimic a potential early response to upregulation in hypertrophy, induced changes in cellular Ca 2ϩ regulation that are quite different from those seen in later, more malignant, stages of the pathology.
METHODS
TG animals. Conditional expression of a constitutively active PKC␤ isoform was carried out using a tetracyclinecontrolled promoter (4, 11) . PKC␤ expression was turned on at the age of 10 wk in binary TG [tTA/PKC␤, which we will refer to as TG (ϩ/ϩ)]. Controls were wild-type mice or single TG, tTA/PKC␤ (ϩ/Ϫ), that do not express PKC␤. As previously reported (4), preparations from single (ϩ/Ϫ) and nontransgenic (NTG) mouse hearts differ in no significant way. The genotype of each animal was determined by either PCR or Southern blotting. Results of comparative determinations of the overall PKC activity indicate that the TG hearts have an ϳ10% increase in activity over the controls. Quantitative RT-PCR (using primers with matched transmembrane segments and real-time fluorescent PCR) has shown that the message level of the transgene was approximately five-to tenfold higher than the endogenous gene and that expression of the transgene does not change the level of expression of the wild-type genes.
Isolation of myocytes. Adult mice were heparinized (5,000 U/kg body wt), and, after 30 min, anesthetized with ether. Left ventricular myocytes were isolated as previously described (32) and were studied 1-6 h after isolation. The cells used for phosphorylation experiments were sequentially resuspended in 0.2, 0.5, and 1.0 mmol/l Ca 2ϩ in a sodium HEPES phosphate-free buffer (pH 7.4) of the following composition (in mmol/l): 4.8 KCl, 1.2 MgSO4, 132 NaCl, 10 HEPES, 2.5 sodium pyruvate, and 10 glucose.
Measurement of intracellular Ca 2ϩ transients and cell shortening. After isolation, the cells were loaded for 15 min at room temperature with 3 mol/l fura 2-AM in Tyrode solution (0.5 mmol/l Ca 2ϩ ) with 1 mg/ml bovine serum albumin and 5% fetal bovine serum. Fura 2 fluorescence and cell shortening were monitored simultaneously, as described in detail by Wolska et. al (33) . Most cells were stimulated at 0.5 Hz, but in one series of experiments, we measured cell shortening over a frequency range of 0.25-3 Hz, with stimulation at each frequency for 30 s, at which time the contractions were stable.
Labeling of mouse myocytes with 32 P and determination of protein phosphorylation. The level of protein phosphorylation in myocyte preparations was measured using a protocol modified after that described by Wolska et al. (33) . Myocytes were incubated for 1 h in a phosphate-free sodium HEPES buffer that contained 1 mM CaCl2 and 0.250 mCi [
32 P]orthophosphate. Myocytes were washed twice and solubilized in 40 l of 1% SDS containing 3 mM EDTA and sonicated for 2 min. The samples were boiled for 10 min before 12.5% SDS-PAGE. Each lane was loaded with 25 g of protein. The gels were stained for 2 h. Destained gels were exposed to a phosphor screen overnight using STORM (Molecular Dynamics) and ImageQuant software to determine the 32 P incorporation after background correction. We used a densitometric scan of the Coomassie blue-stained gel to test for equal loading of the myofilament proteins. Actin and tropomyosin were used as standards and were not statistically different in the NTG and both TG lanes. Therefore, we concluded that any changes in the phosphorylation of the myofilament proteins were the result of increased phosphorylation by PKC␤.
Force measurements on skinned fiber bundles and Ca 2ϩ uptake by SR vesicles. Measurements of the relationship between pCa (Ϫlog of the molar free Ca 2ϩ ) and tension (force/cross-sectional area) were performed on detergent-extracted fiber bundles as described in detail previously (8, 31) . The only modification was addition of the phosphatase inhibitor calyculin A (0.1 M) to the buffers. Ca 2ϩ uptake into SR vesicles in cardiac homogenates was measured with the aid of 45 CaCl2 using a Millipore filtration assay as previously described (8, 22) .
Statistical analysis. Data are presented as means Ϯ SE. The Student's t-test was used for unpaired observations and one-way ANOVA for multiple comparison. P Ͻ 0.05 was considered significant.
RESULTS

Cell shortening and Ca
2ϩ transients in myocytes. Morphological and mechanical properties, as well as stability of the Ca 2ϩ transients, were used as criteria for the viability and stability of the myocytes. Before making measurements, all myocytes were stimulated at 0.5 Hz for at least 20 min or until the shortening was stable for 15-20 min. Representative recordings of myocyte mechanics and Ca 2ϩ transients in cells from 6-mo-old control and TG mice are shown in Fig. 1 . As summarized in Table 1 , the percentage of the extent of myocyte shortening (%l), as well as the rate of shortening and rate of relengthening, was significantly (P Ͻ 0.01) increased in TG (ϩ/ϩ) myocytes compared with controls. Table 1 also indicates that the time required for the cells to achieve 80% of full relaxation from the peak of the shortening signal was reduced significantly in the TG (ϩ/ϩ) mice compared with controls. Table 2 reports data indicating that the amplitude of the Ca 2ϩ transient was significantly increased in the TG (ϩ/ϩ) myocytes. The baseline Ca 2ϩ level was not different between control and TG (ϩ/ϩ) mice. There was also a significant reduction in the time to 50% decay of the Ca 2ϩ signal from its peak in the TG (ϩ/ϩ) mice compared with controls (Table 2 ). These data show that myocytes isolated from hearts conditionally expressing low level PKC␤ demonstrated an increase in contractility.
Data summarized in Table 3 compare results of measurements on myocytes isolated from TG mouse hearts at 10 mo of age with age-matched controls. These myocytes demonstrated increases in extent and velocity of shortening similar to those found at 6 mo of age. Figure 2 illustrates the dependence of these changes on frequency of stimulation over a range from 0.25 to 3 Hz. Both control and TG (ϩ/ϩ) cells showed a negative frequency-shortening relationship. At frequencies of 0.25, 0.5, 1.0, and 2.0 Hz, the percent shortening and the rate of relengthening were increased compared with these same parameters for control myocytes. At a stimulation frequency of 3 Hz, there was no difference in percent shortening and the rate of relengthening between the two groups (Fig. 2) . Thus the effect of PKC␤ expression was sustained over a broad range of frequencies of stimulation. The heart weight-to-body weight ratio for 10-mo-old mouse TG PKC␤ hearts was 8.2 Ϯ 0.6 mg wet heart wt/g body wt and 6.0 Ϯ 0.2 for the controls. Thus the TG hearts demonstrated a significant (P Ͻ 0.01) hypertrophy.
Myofilament tension generation. Figure 3 shows the pCa-tension relations of skinned fiber bundles prepared from 10-mo-old binary TG (ϩ/ϩ) and control mouse ventricles at sarcomere length 2.3 m. Tension generated by these two groups, which was measured in the presence of the phosphatase inhibitor calyculin A, was equally sensitive to Ca 2ϩ . The pCa 50 for binary TG (ϩ/ϩ) preparations was 5.54 Ϯ 0.01 (n ϭ 13 from 4 different hearts) and 5.53 Ϯ 0.02 (n ϭ 13 from 4 different hearts) for controls. However, maximum tension was significantly reduced (P Ͻ 0.01) in the preparations from binary mice (34.6 Ϯ 1.6 mN/mm 2 ) compared with the controls (46.6 Ϯ 2.2 mN/mm 2 ). If both preparations were permitted to dephosphorylate, this difference in maximum tension was no longer evident (data not shown). Thus we cannot ascribe the difference in maximum tension to a difference in the myosin content of the preparations.
Phosphorylation of cardiac proteins. To determine whether differences in covalent modulation among groups, NTG (Ϫ/Ϫ), TG binary (ϩ/ϩ), and single TG Values are means Ϯ SE; n ϭ no. of cells; T50 and T80, times required for cell to achieve 50 and 80% of full relaxation from the peak of shortening; ϩdL/dt, rate of cell shortening; ϪdL/dt, rate of cell relengthening. * P Ͻ 0.05. Values are means Ϯ SE; n ϭ no. of cells; baseline, 340/380 ratio at rest; amplitude, peak of 340/380 ratio Ϫ baseline ratio; T50 and T80, times required for cell to achieve 50 and 80% of full relaxation of Ca 2ϩ signal to baseline ratio from peak ratio. * P Ͻ 0.05.
(ϩ/Ϫ) could account for the decrease in maximum tension, we measured phosphorylation of the cellular proteins. Figure 4 shows an autoradiogram of the cell proteins from the three groups. There were significant increases in the 32 P incorporation into myosin binding protein C (MyBPC; 25%), troponin T (TnT; 39%), TnI (20%), and myosin light chain 2 (MLC2; 60%) in the binary (ϩ/ϩ) TG myocyte preparations, compared with the wild-type (Ϫ/Ϫ) and the single TG (ϩ/Ϫ), which were not different from each other. On the other hand, there was no difference in the incorporation of 32 
P into phospholamban.
SR Ca 2ϩ -uptake rates. The effects of PKC expression on the initial rates of ATP-dependent SR Ca 2ϩ uptake facilitated with oxalate were assessed using cardiac homogenates. Figure 5 shows the initial rates of Ca 2ϩ uptake by vesicles of SR, which were assayed at various Ca 2ϩ concentrations. The maximum uptake rate by the SR vesicles of TG mouse hearts (421.9 Ϯ 28.1 nmol ⅐ mg Ϫ1 ⅐ min Ϫ1 ) was not significantly different than the uptake rate of controls (441.5 Ϯ 27.4 nmol ⅐ mg Ϫ1 ⅐ min
Ϫ1
). EC 50 values for Ca 2ϩ dependence of uptake rates were 6.49 Ϯ 0.06 M for controls and 6.51 Ϯ 0.05 M for TG.
DISCUSSION
Using a TG model that allows conditional expression of PKC in the heart, we have been able to shed light on the genesis of hypertrophic process and postulate how failure may follow. The major novel finding of our study is that physiologically relevant, cardiac-specific expression of PKC, initiated in adult life, produces significant inotropic enhancement, as measured by unloaded rates of cell shortening and relaxation. These changes are mirrored by increases in the dynamics and peak amplitude of the Ca 2ϩ transient and are associated with significant cellular hypertrophy. It is also apparent that these changes occur against a background of reduced maximum tension-generating capability of the myofilaments with no change in myofilament Ca 2ϩ sensitivity. This scenario is in sharp contrast with the changes induced by constitutive overexpression of PKC␤ in which there is a 20-fold increase in expression of cytoplasmic PKC and a 10-fold increase in bound PKC (26, 27 ). These models demonstrate high levels of PKC expression and activity from birth through adult life and induce depressed myocyte contractility without change in the dynamics of the Ca 2ϩ transient. Together, these two lines of evidence indicate that there may be a hierarchy of PKC effects in the adult cardiocyte, initially characterized by a balance of increased cellular Ca 2ϩ availability and depressed myofilament activity in association with mild, well-compensated hypertrophy. Our data also indicate that the balance of responses to PKC activation may change in favor of depressed myofilament activity with the progression from compensated hypertrophy to decompensated heart failure.
The cellular address where enhancement of Ca 2ϩ fluxes resides appears to be the sarcolemma and not the SR, inasmuch as we were unable to demonstrate altered rates of Ca 2ϩ uptake by vesicles of the SR in preparations from TG hearts. We cannot, however, rule out a possible effect of PKC on Ca 2ϩ release via the ryanodine receptor (13, 16) . L-type Ca 2ϩ channels are likely candidates for the action of PKC␤. There are several reports demonstrating that PKC phosphorylation enhances Ca 2ϩ influx during the action potential. Moreover, PKC activators, such as phorbol esters and diacylglycerols, increase Ca 2ϩ -channel currents in cardiac and smooth muscle cells of various mammals (6, 34) . In addition, our own data from studies on neonatal cardiocytes expressing the PKC␤ transgene demonstrate both a prolongation of the Ca 2ϩ transient (4) and also an increase in the Ca 2ϩ conductance through the L-type Ca 2ϩ channel that is blocked by a specific PKC␤ 2 antagonist (1).
An alternate mechanism by which PKC might affect contractility is by PKC-dependent phosphorylation of the myofilament proteins cTnI, cardiac TnT (cTnT), MLC2, and MyBPC (23). Our results represent the first explicit determination of the net effect of protein phosphorylation on myofilament response to Ca 2ϩ in a TG model of PKC expression. Our data show a depression in maximum tension with no effect on Ca 2ϩ sensitivity. Earlier studies, including our own, have investigated effects of specific phosphorylation of the main sites: cTnI, cTnT, MyBPC, and MLC2. Among these sites, PKC-dependent phosphorylation of only two, cTnI and cTnT, have been reported to depress maximum actinactivated myosin ATPase rate and maximum crossbridge binding to the thin filament, even at saturating Ca 2ϩ (14, 18, 19) . Also, phosphorylation of MLC2 has no effect on maximum tension (17) . Phosphorylation of TnI may reduce Ca 2ϩ sensitivity (29) , and phosphorylation of MLC2 may increase Ca 2ϩ sensitivity of force (17) and thus have offsetting effects. This finding is significant in that it demonstrates that when both are phosphorylated, covalent modulation of cTnI may outweigh the impact of modulation of MLC2 and impose a depression of myofilament of Ca 2ϩ sensitivity. We (9, 29) could find no effect of MyBPC-protein phosphorylation on Ca 2ϩ sensitivity or ATPase and maximum tension. On the other hand, phosphorylation of MyBPC may possibly be related, in part, to the enhanced rate of shortening of the isolated myocytes (30) .
Our data indicate that at different stages of cardiac hypertrophy, there is a shifting balance between the positive effects of PKC on the Ca 2ϩ -channel conductance and the depressive effects of PKC activation on the myofilaments. Our conclusion from the studies presented here is that the increase in the amplitude of the Ca 2ϩ transient overrides the depression in maximum tension. The depression in maximum tension was an ϳ25% decrease, whereas there was an 85% increase in the rate of cell shortening (ϩdL/dt) of the myocytes and an increase of 160% in the amplitude of the Ca 2ϩ transient. The steepness of the relationship between Ca 2ϩ and tension would indicate that this increase in Ca 2ϩ delivery to the myofilaments would indeed increase contractility, despite a blunted maximum tension. It remains a distinct possibility that the increased Ca 2ϩ could also trigger and promote the other features of the hypertrophic phenotype, including PKC activation of phosphorylation cascades affecting transcription (25) . In models of heart failure in which sustained activation of PKC can be demonstrated (including prolonged insulin-deficient diabetes, end-stage cardiomyopathy, and TG constitutive expression of PKC), we propose that this balance may be tilted in favor of the negative inotropic effects of myofilament protein phosphorylation, especially of cTnI and cTnT. This proposal fits with data of de Tombe (7), who reported that the early hypertrophic response following myocardial infarction in rats was associated with a normal Ca 2ϩ -tension relationship in skinned trabeculae. However, aftersigns of congestive heart failure had become man- ifest; the Ca 2ϩ -tension relationship was rightshifted and depressed, compared with sham-operated controls. Moreover, previous studies (4) comparing controls with the TG model employed in the present study reported a depression in maximum pressure development in left ventricles of open-chest mice 9 mo after the PKC␤ gene was turned on. This result fits with our finding (Fig. 3 ) of a depression in maximum tension-generating capability of the myofilaments 10 mo after PKC␤ was turned on.
What is not directly addressed in the present study is the role played by specific isoforms of PKC. In the adult mouse heart, the prominent isoforms are Ca 2ϩ independent (⑀ and ␦), although Ca 2ϩ -dependent isoforms are also seen (24) . Whether the ␤-isoform is expressed in nonpathological adult cardiac myocytes is controversial. However, during fetal life and in response to pathological loads, increased expression is seen (10) . The cellular functions subserved by individual isoforms are not established. PKC⑀ appears to translocate to the sarcomere when activated and has been shown to have a high affinity for TnI (14) . In contrast, phosphorylation of the L-type Ca 2ϩ channel has been linked to the Ca 2ϩ -dependent ␣-and ␤-isoforms (35) .
Despite extensive data from in vivo and in vitro experiments linking PKC activation to the development of pathological cardiac adaptations, the mechanism(s) by which kinase activation induces a hypertrophic response remains elusive. PKC influences a number of intracellular processes, including transcriptional transactivation of late response genes (25) , alterations in cellular Ca 2ϩ fluxes (5, 15, 28) , and altered response of the myofilaments to Ca 2ϩ (11, 14, 19) . Because it is difficult to recapitulate the in vivo situation on isolated cells or protein preparations, defining the relevance of each of these effects has been aided greatly by TG approaches. We have investigated a novel TG mouse model to establish that low levels of PKC␤ activation in the adult cardiocyte are sufficient to cause cardiac hypertrophy. The hypertrophy is characterized by an increase in the amplitude of the Ca 2ϩ transient and increased rates of cell shortening, despite a depression of maximum tension-generating capability by the myofilaments. In contrast, more substantial increases in transgene expression and enzyme activation have been reported to induce reduced rates of cell shortening and a rightshifted Ca 2ϩ -tension relationship associated with in vivo evidence of heart failure (26) . Our findings support the hypothesis that there is a hierarchy of effects of enzyme activation in the cardiocyte and that the progression from compensated to uncompensated hypertrophy and failure may be a reflection of the intensity or duration of activation of this second messenger pathway.
